Design and Evaluation of a Robust PID Controller for a Fully Implantable Artificial Pancreas

被引:62
作者
Huyett, Lauren M. [1 ]
Dassau, Eyal [1 ]
Zisser, Howard C. [1 ]
Doyle, Francis J., III [1 ]
机构
[1] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
INSULIN-PUMP THERAPY; CLOSED-LOOP SYSTEM; SUBCUTANEOUS INSULIN; GLYCEMIC CONTROL; INTRAPERITONEAL; GLUCOSE; DELIVERY; INFUSION; HYPOGLYCEMIA; FEASIBILITY;
D O I
10.1021/acs.iecr.5b01237
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
Treatment of type 1 diabetes mellitus could be greatly improved by applying a closed-loop control strategy to insulin delivery, also known as an artificial pancreas (AP). In this work, we outline the design of a fully implantable AP using intraperitoneal (IP) insulin delivery and glucose sensing. The design process utilizes the rapid glucose sensing and insulin action offered by the IP space to tune a PM controller with insulin feedback to provide safe and effective insulin delivery. The controller was tuned to meet robust performance and stability specifications. An anti-reset windup strategy was introduced to prevent dangerous undershoot toward hypoglycemia after a large meal disturbance. The final controller design achieved 78% of time within the tight glycemic range of 80-140 mg/dL, with no time spent in hypoglycemia. The next step is to test this controller design in an animal model to evaluate the in vivo performance.
引用
收藏
页码:10311 / 10321
页数:11
相关论文
共 53 条
  • [1] INSULIN SUPPRESSES ITS OWN SECRETION INVIVO
    ARGOUD, GM
    SCHADE, DS
    EATON, RP
    [J]. DIABETES, 1987, 36 (08) : 959 - 962
  • [2] Basu Ananda, 2015, J Diabetes Sci Technol, V9, P63, DOI 10.1177/1932296814554797
  • [3] Time Lag of Glucose From Intravascular to Interstitial Compartment in Humans
    Basu, Ananda
    Dube, Simmi
    Slama, Michael
    Errazuriz, Isabel
    Amezcua, Jose Carlos
    Kudva, Yogish C.
    Peyser, Thomas
    Carter, Rickey E.
    Cobelli, Claudio
    Basu, Rita
    [J]. DIABETES, 2013, 62 (12) : 4083 - 4087
  • [4] Bélicar PS, 2003, DIABETES METAB, V29, P344
  • [5] Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
    Bergenstal, Richard M.
    Tamborlane, William V.
    Ahmann, Andrew
    Buse, John B.
    Dailey, George
    Davis, Stephen N.
    Joyce, Carol
    Peoples, Tim
    Perkins, Bruce A.
    Welsh, John B.
    Willi, Steven M.
    Wood, Michael A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (04) : 311 - 320
  • [6] Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production
    Boden, G
    Chen, XH
    Urbain, JL
    [J]. DIABETES, 1996, 45 (08) : 1044 - 1050
  • [7] COMPARISON OF PERIPHERAL AND PORTAL ROUTES OF INSULIN INFUSION BY A COMPUTER-CONTROLLED INSULIN INFUSION SYSTEM (ARTIFICIAL ENDOCRINE PANCREAS)
    BOTZ, CK
    LEIBEL, BS
    ZINGG, W
    GANDER, RE
    ALBISSER, AM
    [J]. DIABETES, 1976, 25 (08) : 691 - 700
  • [8] Breton Marc, 2008, J Diabetes Sci Technol, V2, P853
  • [9] Glucose Sensing in the Peritoneal Space Offers Faster Kinetics Than Sensing in the Subcutaneous Space
    Burnett, Daniel R.
    Huyett, Lauren M.
    Zisser, Howard C.
    Doyle, Francis J., III
    Mensh, Brett D.
    [J]. DIABETES, 2014, 63 (07) : 2498 - 2505
  • [10] Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes
    Castle, Jessica R.
    Engle, Julia M.
    Youssef, Joseph E. L.
    Massoud, Ryan G.
    Yuen, Kevin C. J.
    Kagan, Ryland
    Ward, W. Kenneth
    [J]. DIABETES CARE, 2010, 33 (06) : 1282 - 1287